Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy OncoSec Medical stock

Learn how to easily invest in OncoSec Medical stock.

OncoSec Medical Inc is a biotechnology business based in the US. OncoSec Medical shares (ONCS) are listed on the NASDAQ and all prices are listed in US Dollars. OncoSec Medical employs 54 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in OncoSec Medical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ONCS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

OncoSec Medical stock price (NASDAQ: ONCS)

Use our graph to track the performance of ONCS stocks over time.

OncoSec Medical shares at a glance

Information last updated 2022-10-04.
Latest market close$0.50
52-week range$0.47 - $2.08
50-day moving average $0.65
200-day moving average $0.85
Wall St. target price$5.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.96

Buy OncoSec Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OncoSec Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OncoSec Medical price performance over time

Historical closes compared with the close of $0.5 from 2022-10-03

1 week (2022-09-28) 0.5
1 month (2022-09-02) -26.63%
3 months (2022-07-05) -31.02%
6 months (2022-04-05) -56.52%
1 year (2021-10-05) -75.49%
2 years (2020-10-05) -86.52%
3 years (2019-10-04) 1.84
5 years (2017-10-05) 1.015

OncoSec Medical financials

Gross profit TTM $0
Return on assets TTM -55.88%
Return on equity TTM -123.19%
Profit margin 0%
Book value $0.35
Market capitalisation $19.5 million

TTM: trailing 12 months

OncoSec Medical share dividends

We're not expecting OncoSec Medical to pay a dividend over the next 12 months.

Have OncoSec Medical's shares ever split?

OncoSec Medical's shares were split on a 1:10 basis on 21 May 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OncoSec Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for OncoSec Medical shares which in turn could have impacted OncoSec Medical's share price.

OncoSec Medical share price volatility

Over the last 12 months, OncoSec Medical's shares have ranged in value from as little as $0.47 up to $2.08. A popular way to gauge a stock's volatility is its "beta".

ONCS.US volatility(beta: 1.87)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OncoSec Medical's is 1.873. This would suggest that OncoSec Medical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OncoSec Medical overview

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co. , Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute.

Frequently asked questions

What percentage of OncoSec Medical is owned by insiders or institutions?
Currently 55.943% of OncoSec Medical shares are held by insiders and 14.022% by institutions.
How many people work for OncoSec Medical?
Latest data suggests 54 work at OncoSec Medical.
When does the fiscal year end for OncoSec Medical?
OncoSec Medical's fiscal year ends in July.
Where is OncoSec Medical based?
OncoSec Medical's address is: 24 North Main Street, Pennington, NJ, United States, 08534
What is OncoSec Medical's ISIN number?
OncoSec Medical's international securities identification number is: US68234L3069
What is OncoSec Medical's CUSIP number?
OncoSec Medical's Committee on Uniform Securities Identification Procedures number is: 68234L108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site